Knowledge Of Biosimilars: Survey Of 100+ U.S. Rheumatologists Shows Familiarity But Need For Further Education
RIDGEFIELD, Conn., Dec. 20, 2017 /PRNewswire/ -- A Boehringer Ingelheim survey of U.S. rheumatologists shows familiarity with biosimilars but a need for education.
Contact:
Boehringer Ingelheim Pharmaceuticals, Inc.
Name: Susan Holz
Phone: 203-798-4265
Email: [email protected]
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Share this article